BRCA1 and breast neoplasm: We can apply the same reasoning to question the association between the other aggressive features of the MBT group and BRCA1 promoter methylation reported in this study, especially since there are shared clinical and molecular features (BRCAness) between breast tumors associated with BRCA1 mutations and those with BRCA1 promoter methylation, as previously noted [8].